These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38198446)

  • 41. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
    Moore N; Gulmez SE; Larrey D; Pageaux GP; Lignot S; Lassalle R; Jové J; Pariente A; Blin P; Bénichou J; Bégaud B
    Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):160-7. PubMed ID: 23166053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.
    Kaplan YC; Ozsarfati J; Etwel F; Nickel C; Nulman I; Koren G
    Br J Dermatol; 2015 Nov; 173(5):1132-41. PubMed ID: 26215715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
    BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dutch trends in the use of potentially harmful medication during pregnancy.
    Houben E; Te Winkel B; Steegers EAP; Herings RMC
    Br J Clin Pharmacol; 2020 Dec; 86(12):2377-2392. PubMed ID: 32374086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What do pregnant women know about non-steroidal anti-inflammatory drugs?
    Damase-Michel C; Christaud J; Berrebi A; Lacroix I; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1034-8. PubMed ID: 19634118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First trimester naproxen exposure and outcome of pregnancy - A German case series.
    Hultzsch S; Paulus W; Padberg S; Fietz AK; Schaefer C; Dathe K
    Reprod Toxicol; 2021 Aug; 103():51-57. PubMed ID: 34015472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France.
    Coste J; Blotiere PO; Miranda S; Mikaeloff Y; Peyre H; Ramus F; Zureik M; Weill A; Dray-Spira R
    Sci Rep; 2020 Oct; 10(1):17362. PubMed ID: 33093466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teratogen update: Topical use and third-generation retinoids.
    Williams AL; Pace ND; DeSesso JM
    Birth Defects Res; 2020 Sep; 112(15):1105-1114. PubMed ID: 32643315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
    Vannappagari V; Albano JD; Koram N; Tilson H; Scheuerle AE; Napier MD
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():6-10. PubMed ID: 26687320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
    Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.
    Brin MF; Kirby RS; Slavotinek A; Adams AM; Parker L; Ukah A; Radulian L; Elmore MRP; Yedigarova L; Yushmanova I
    Neurology; 2023 Jul; 101(2):e103-e113. PubMed ID: 37137724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes.
    Ray JG; Vermeulen MJ; Bharatha A; Montanera WJ; Park AL
    JAMA; 2016 Sep; 316(9):952-61. PubMed ID: 27599330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
    Nørgård B; Fonager K; Pedersen L; Jacobsen BA; Sørensen HT
    Gut; 2003 Feb; 52(2):243-7. PubMed ID: 12524407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pregnancy in women who have epilepsy.
    Pennell PB
    Neurol Clin; 2004 Nov; 22(4):799-820. PubMed ID: 15474768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teratogenic determinants of first-trimester exposure to antiepileptic medications.
    Brosh K; Matok I; Sheiner E; Koren G; Wiznitzer A; Gorodischer R; Levy A
    J Popul Ther Clin Pharmacol; 2011; 18():e89-98. PubMed ID: 21467600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of diclofenac use during early pregnancy: A prospective observational cohort study.
    Padberg S; Tissen-Diabaté T; Dathe K; Hultzsch S; Meixner K; Linsenmeier V; Meister R; Schaefer C
    Reprod Toxicol; 2018 Apr; 77():122-129. PubMed ID: 29477808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester.
    Koren G; Bologa M; Long D; Feldman Y; Shear NH
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1190-4. PubMed ID: 2729394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
    Bernard N; Elefant E; Carlier P; Tebacher M; Barjhoux CE; Bos-Thompson MA; Amar E; Descotes J; Vial T
    BJOG; 2013 Apr; 120(5):568-74. PubMed ID: 23346916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.